BioCryst Pharmaceuticals | BCRX - EPS Earnings Per Share


BioCryst Pharmaceuticals reported $0.3 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.





Eps Change Date
Alnylam Pharmaceuticals USD 1.84 0.15 Jun/2026
BioCryst Pharmaceuticals USD 0.3 0.87 Jun/2026
Chugai Pharma JPY 70.69 0.56 Jun/2026
Daiichi Sankyo JPY 37.72 11.03 Jun/2026
DBV Technologies USD -0.55 0.31 Mar/2026
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Gilead Sciences USD -6.75 8.78 Jun/2026
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
Glaxosmithkline GBP 0.62 0.41 Mar/2026
Incyte USD 3.09 1.28 Jun/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
Novavax USD 0.13 0.59 Dec/2025
PTC Therapeutics USD 0.92 0.95 Jun/2026
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sarepta Therapeutics USD 0.64 2.52 Jun/2026
Ultragenyx Pharmaceutical USD -0.9 0.94 Jun/2026
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026